Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("population pharmacokinetics")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 826

  • Page / 34
Export

Selection :

  • and

Some considerations on the design of population pharmacokinetic studiesDUFFULL, Stephen; WATERHOUSE, Tim; ECCLESTON, John et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2005, Vol 32, Num 3-4, pp 441-457, issn 1567-567X, 17 p.Article

Methods to Account for Inaccuracies in the Dosing History When Performing Population Pharmacokinetic AnalysisPAVAN KUMAR, Venkata V; DUFFULL, Stephen B.Pharmaceutical research. 2008, Vol 25, Num 12, pp 2740-2749, issn 0724-8741, 10 p.Article

Population pharmacokinetic model of PI-88, a heparanase inhibitorHUDACHEK, Susan F; ECKHARDT, S. Gail; HICKS, Barbara et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 4, pp 743-753, issn 0344-5704, 11 p.Article

Understanding the time course of pharmacological effect: a PKPD approachWRIGHT, Daniel F. B; WINTER, Helen R; DUFFULL, Stephen B et al.British journal of clinical pharmacology. 2011, Vol 71, Num 6, pp 815-823, issn 0306-5251, 9 p.Article

Population pharmacokinetics of ceftazidime in burn patientsDAILLY, Eric; PANNIER, Michel; JOLLIET, Pascale et al.British journal of clinical pharmacology. 2003, Vol 56, Num 6, pp 629-634, issn 0306-5251, 6 p.Article

Discrepancies in pharmacokinetic analysis results obtained by using two standard population pharmacokinetics software programsFINKELSTEIN, Yaron; NAVA-DCAMPO, Alejandro A; SCHECHTER, Tal et al.Fundamental & clinical pharmacology. 2009, Vol 23, Num 1, pp 53-57, issn 0767-3981, 5 p.Article

Dealing with time-dependent pharmacokinetics during the early clinical development of a new leukotriene B4 synthesis inhibitorTROCONIZ, Inaki F; ZSOLT, Ilonka; GARRIDO, Maria J et al.Pharmaceutical research. 2006, Vol 23, Num 7, pp 1533-1542, issn 0724-8741, 10 p.Article

Population approaches in paediatricsCHATELUT, Etienne.Fundamental & clinical pharmacology. 2008, Vol 22, Num 6, pp 575-578, issn 0767-3981, 4 p.Conference Paper

Population pharmacokinetics. III: Design, analysis, and application of population pharmacokinetic studiesETTE, Ene I; WILLIAMS, Paul J; LANE, James R et al.The Annals of pharmacotherapy. 2004, Vol 38, Num 12, pp 2136-2144, issn 1060-0280, 9 p.Article

Statistical issues in a modeling approach to assessing bioequivalence or PK similarity with presence of sparsely sampled subjectsCHUANPU HU; MOORE, Katy H. P; KIM, Yong H et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2004, Vol 31, Num 4, pp 321-339, issn 1567-567X, 19 p.Article

Population pharmacokinetic analysis of carboxyhaemoglobin concentrations in adult cigarette smokersCRONENBERGER, Carol; MOULD, Diane R; ROETHIG, Hans-Juergen et al.British journal of clinical pharmacology. 2008, Vol 65, Num 1, pp 30-39, issn 0306-5251, 10 p.Article

Population pharmacokinetic modeling : the importance of informative graphicsETTE, E. I; LUDDEN, T. M.Pharmaceutical research. 1995, Vol 12, Num 12, pp 1845-1855, issn 0724-8741Article

Mechanistic modelling of tesaglitazar pharmacokinetic data in subjects with various degrees of renal function -evidence of interconversionHAMREN, Bengt; ERICSSON, Hans; SAMUELSSON, Ola et al.British journal of clinical pharmacology. 2008, Vol 65, Num 6, pp 855-863, issn 0306-5251, 9 p.Article

Cluster analysis : An alternative method for covariate selection in population pharmacokinetic modelingSEMMAR, Nabil; BRUGUEROLLE, Bernard; BOULLU-CIOCCA, Sandrine et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2005, Vol 32, Num 3-4, pp 333-358, issn 1567-567X, 26 p.Article

Estimation of population pharmacokinetic parameters in the presence of non-complianceSONG MU; LUDDEN, Thomas M.Journal of pharmacokinetics and pharmacodynamics (Print). 2003, Vol 30, Num 1, pp 53-81, issn 1567-567X, 29 p.Article

Oxycodone clearance is markedly reduced with advancing age: a population pharmacokinetic studySAARI, T. I; IHMSEN, H; NEUVONEN, P. J et al.British journal of anaesthesia. 2012, Vol 108, Num 3, pp 491-498, issn 0007-0912, 8 p.Article

ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavirLUBOMIROV, Rubin; DI IULIO, Julia; LEDERGERBER, Bruno et al.Pharmacogenetics and genomics (Print). 2010, Vol 20, Num 4, pp 217-230, issn 1744-6872, 14 p.Article

Applications of population pharmacokinetics in current drug labellingDUAN, J. Z.Journal of clinical pharmacy and therapeutics (Print). 2007, Vol 32, Num 1, pp 57-79, issn 0269-4727, 23 p.Article

Population pharmacokinetics of darbepoetin alfa in healthy subjectsAGORAM, Balaji; SUTJANDRA, Liviawati; SULLIVAN, John T et al.British journal of clinical pharmacology. 2007, Vol 63, Num 1, pp 41-52, issn 0306-5251, 12 p.Article

Population pharmacokinetic investigation of disopyramide by mixed effect modelling using routine clinical pharmacokinetic data in Japanese patientsYUKAWA, E; ORIO, K; YUKAWA, M et al.Journal of clinical pharmacy and therapeutics (Print). 2005, Vol 30, Num 4, pp 401-405, issn 0269-4727, 5 p.Article

Estimation of glomerular filtration rate in paediatric cancer patients using 51CR-EDTA population pharmacokineticsCOLE, M; PRICE, L; PARRY, A et al.British journal of cancer. 2004, Vol 90, Num 1, pp 60-64, issn 0007-0920, 5 p.Article

Population pharmacokinetics of orally administered paclitaxel formulated in Cremophor ELDE JONGE, Milly E; HUITEMA, Alwin D. R; SCHELLENS, Jan H. M et al.British journal of clinical pharmacology. 2005, Vol 59, Num 3, pp 325-334, issn 0306-5251, 10 p.Article

Population pharmacokinetics of itraconazole solution used as prophylaxis for febrile neutropeniaKANBAYASHI, Yuko; NOMURA, Kenichi; TANIWAKI, Masafumi et al.International journal of antimicrobial agents. 2008, Vol 31, Num 5, pp 452-457, issn 0924-8579, 6 p.Article

Population pharmacokinetics of arbekacin in burn patientsJONG HYUN KIM; LAH, Hyon-Oh; YIM, Dong-Seok et al.European journal of clinical pharmacology. 2008, Vol 64, Num 6, pp 599-603, issn 0031-6970, 5 p.Article

Population pharmacokinetic modelling of BIBN 4096 BS, the first compound of the new class of calcitonin gene-related peptide receptor antagonistsTROCONIZ, Inaki F; WOLTERS, Jan-Markus; SCHAEFER, Hans Guenter et al.European journal of pharmaceutical sciences. 2004, Vol 22, Num 4, pp 287-295, issn 0928-0987, 9 p.Article

  • Page / 34